Report Ocean presents a new report on sarcopenia treatment market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for predicting the market’s future.
The global sarcopenia treatment market is forecast to grow at a compound annual growth rate (CAGR) of more than 6% during the forecast period from 2021-2030, and the market value anticipates to reach USD 4700 million by 2030.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC604
A condition known as sarcopenia occurs when skeletal muscle mass or flesh decreases with aging. Reduced muscle mass, relative weakness, a lack of stamina, and problems climbing stairs are some of the symptoms of sarcopenia. In addition, to exercise level and co-morbidities, there are other factors affecting muscle loss. Sarcopenia can impair quality of life and lead to disability. The aging process causes muscles to lose strength and muscle mass.
Malnutrition is a result of low consumption of micronutrient-rich foods in developing and low-income countries. It results from malnutrition or vitamin D and vitamin B12 deficiency. Vegetarians and the elderly are more at risk for this condition. Therefore, sarcopenia has no recognized treatment; however, proper nutrition and dietary supplements can help. During periods of muscle inactivity, diet prevents accelerated muscle loss and keeps energy levels up. A few of the most effective supplements for treating sarcopenia are proteins, amino acids, omega-3 fatty acids, creatine, vitamin D, and vitamin B12.
Factors Affecting
Factors driving the global sarcopenia treatment market include an aging population and the increasing acceptance of vitamins and dietary supplements. The World Health Organization predicts that by 2050, there will be 2 billion people aged 60 and older in the world, up from 900 million in 2015. Furthermore, a rise in sarcopenia cases will drive the growth of treatment products for the condition.
Sarcopenia treatment market growth will also benefit from an increase in R&D activities.
During the forecast period, high protein supplement prices and a lack of awareness will hinder the market growth.
As malnutrition and vitamin deficiency rise in developing countries and healthcare spending rises per capita, sarcopenia treatment supplements will likely become more in demand.
The increase in malnutrition cases resulting from poor nutrition will provide additional growth opportunities for the sarcopenia treatment market during the forecast period.
Despite these obstacles, protein supplement prices could increase, and sarcopenia treatment drugs will become more difficult to acquire.
Impact Analysis of COVID-19
The COVID-19 study may boost sarcopenia treatment market growth. COVID-19 infection causes a systematic inflammation that leads to skeletal muscle death in patients with sarcopenia. In addition, older people who suffered social isolation during the COVID-19 pandemic suffered protein deficiencies and reduced physical activity, which lead to accelerated muscle weakness and dysfunction. Those with COVID-19 are also likely to experience secondary sarcopenia for two or three weeks after diagnosis. The result was an increase in the demand for protein supplements that promote muscle growth and increase muscle strength. A secondary recommendation should be to have physically isolated individuals do daily exercises such as ViviFrail graded exercise, the primary treatment for sarcopenia. COVID-19 has therefore grown positively as a result of such factors.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC604
Regional Overview
The Asia-Pacific region accounted for the largest share, continuing to retain its dominance through 2030 due to high R&D spending, the presence of leading players and their products, and well-established healthcare infrastructure.
Prominent Players
The prominent players profiled in the global sarcopenia treatment market are:
Abbott Laboratories, Inc. (U.S.)
American Way (Amway) Corporation (U.S.)
Bayer AG (Germany)
GlaxoSmithKline plc. (U.K.)
Nestle S.A. (Europe)
Pfizer, Inc. (U.S.)
Novartis AG (Europe)
Sanofi, Inc. (France)
Zydus Cadila, Ltd (India)
F-Hoffmann La-Roche (Europe)
Other Prominent Players
Scope of the Report
The global sarcopenia market segmentation focuses on Treatment, Route of Administration, Distribution Channel, and Region.
Segmentation based on Treatment
Protein Supplements
Vitamin B12 Supplements
Vitamin D & Calcium Supplements
Others
Segmentation based on Route of Administration
Oral
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Parenteral
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Enteral
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Segmentation based on Distribution Channel
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Get a Sample PDF copy of the report:-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC604
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America
What are the aspects of this report that relate to regional analysis?
The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.
Reports on the market include the growth rates of each region, which includes their countries, over the coming years.
How are the key players in the market assessed?
This report provides a comprehensive analysis of leading competitors in the market.
The report includes information about the key vendors in the market.
The report provides a complete overview of each company, including its profile, revenue generation, cost of goods, and products manufactured.
The report presents the facts and figures about market competitors, alongside the viewpoints of leading market players.
A market report includes details on recent market developments, mergers, and acquisitions involving the key players mentioned.
Access full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC604
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/
